Clinical trial
Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum Resection: a Double-blind Placebo-controlled Clinical Trial
NCT05941806 is registered in ClinicalTrials.gov with CHU de Quebec-Universite Laval as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum Resection: a Double-blind Placebo-controlled Clinical Trial
- Lead sponsor
- CHU de Quebec-Universite Laval
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- November 10, 2023
- Completion date
- July 30, 2028
- Enrollment
- 220 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal surgery, post-operative urinary retention, rectal resection, tamsulosin, urinary retention